跳至主要内容
临床试验/NCT04434261
NCT04434261Unknown不适用

Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2

Instituto Brasileiro de Controle do Cancer1 个研究点 分布在 1 个国家目标入组 1,500 人开始时间: 2020年5月11日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,500
试验地点
1
主要终点
Incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program

研究概览

简要总结

To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution

详细描述

Cohort, prospective, observational study to evaluate the incidence of asymptomatic patients with a positive SARS-CoV-2 test detected in the preoperative screening program of the institution.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with elective surgery scheduled at the IBCC, including those diagnosed with any type of cancer;
  • Patients who will undergo the screening test for SARS-COV-2 by RT-PCR (nasal swab), according to the guidelines and protocol of the hospital

排除标准

  • Urgent or emergency surgery;
  • Screening test for SARS-COV-2 not performed
  • Incomplete data in the institutional database

结局指标

主要结局

Incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program

时间窗: May- December 2020

Describe the incidence of patients with a positive test for SARS-CoV-2, detected in the preoperative screening program in our center

次要结局

  • Postoperative complications(Up to 30 days)
  • Incidence of SARS-CoV-2 infection in the postoperative period in patients with negative screening test;(Up to 30 days)
  • Delay in the cancer treatment(May 2020- March 2021)
  • Mortality(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Oncological Surgery in Times of COVID-19:... | 临床试验